Abstract
Lynch syndrome (LS) is characterized by the development of mismatch repair–deficient (dMMR) colorectal and endometrial cancers at a young age in life. LS is caused by germline pathogenic variants (PVs) in 1 of the MMR genes MLH1, MSH2, MSH6, or PMS2 or deletions affecting the 3′ region of EPCAM.1 Current germline diagnostics for LS include targeted short-read sequencing and multiplex ligation-dependent probe amplification of the coding regions of the MMR genes, after the exclusion of somatic MLH1-promoter hypermethylation.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
